Mutational activation of BRAF is the earliest and most common genetic alteration in human
melanoma. To build a model of human melanoma, we generated mice with conditional …

New molecularly targeted therapeutics are changing dermatologic therapy. Janus kinase–signal
transducer and activator of transcription (JAK-STAT) is an intracellular signaling …

Pathologic immune hyperactivation is emerging as a key feature of critical illness in COVID-19,
but the mechanisms involved remain poorly understood. We carried out proteomic …

Malignant melanoma is characterized by frequent metastasis, however, specific changes that
regulate this process have not been clearly delineated. Although it is well known that Wnt …

Tumours use various strategies to evade immune surveillance 1 , 2 . Immunotherapies
targeting tumour immune evasion such as immune checkpoint blockade have shown …

Cytokines were the first modern immunotherapies to produce durable responses in patients
with advanced cancer, but they have only modest efficacy and limited tolerability 1 , 2 . In an …

Background Cutaneous reactions after COVID-19 vaccination have been commonly
reported; however, histopathologic features and clinical correlations have not been well …

Colony-stimulating factor 1 (CSF1) is a key regulator of monocyte/macrophage differentiation
that sustains the protumorigenic functions of tumor-associated macrophages (TAMs). We …

The remarkable success of immune therapies emphasizes the need for immune‐competent
cancer models. Elegant genetically engineered mouse models of a variety of cancers have …

Metastasis accounts for the vast majority of morbidity and mortality associated with melanoma.
Evidence suggests melanoma has a predilection for metastasis to particular organs. …